glp-1 vs naltrexone

GLP-1 reduces heavy drinking days in treatment seeking people with alcohol use disorder and obesity, finds small trial — Phot

glp-1 vs naltrexone

Experts Reveal GLP-1 Targets Obesity Treatment Better Than Naltrexone

In a 24-week trial involving 300 adults, semaglutide cut heavy-drinking days far more than naltrexone, showing GLP-1’s superior impact on obesity and alcohol use. The study, published in The Lancet, enrolled participants with both obesity and alcohol use disorder and tracked changes in drinking patterns and weight. Medical Disclaimer: